Fracture prediction from repeat BMD measurements in clinical practice
- PMID: 26243362
- DOI: 10.1007/s00198-015-3259-y
Fracture prediction from repeat BMD measurements in clinical practice
Abstract
We investigated whether repeat BMD measurements in clinical populations are useful for fracture risk assessment. We report that repeat BMD measurements are a robust predictor of fracture in clinical populations; this is not affected by preceding BMD change or recent osteoporosis therapy.
Introduction: In clinical practice, many patients selectively undergo repeat bone mineral density (BMD) measurements. We investigated whether repeat BMD measurements in clinical populations are useful for fracture risk assessment and whether this is affected by preceding change in BMD or recent osteoporosis therapy.
Methods: We identified women and men aged ≥ 50 years who had a BMD measurement during 1990-2009 from a large clinical BMD database for Manitoba, Canada (n = 50,215). Patient subgroups aged ≥ 50 years at baseline with repeat BMD measures were identified. Data were linked to an administrative data repository, from which osteoporosis therapy, fracture outcomes, and covariates were extracted. Using Cox proportional hazards models, we assessed covariate-adjusted risk for major osteoporotic fracture (MOF) and hip fracture according to BMD (total hip, lumbar spine, femoral neck) at different time points.
Results: Prevalence of osteoporosis therapy increased from 18 % at baseline to 55 % by the fourth measurement. Total hip BMD was predictive of MOF at each time point. In the patient subgroup with two repeat BMD measurements (n = 13,481), MOF prediction with the first and second measurements was similar: adjusted-hazard ratio (HR) per SD 1.45 (95 % CI 1.34-1.56) vs. 1.64 (95 % CI 1.48-1.81), respectively. No differences were seen when the second measurement results were stratified by preceding change in BMD or osteoporosis therapy (both p-interactions >0.2). Similar results were seen for hip fracture prediction and when spine and femoral neck BMD were analyzed.
Conclusion: Repeat BMD measurements are a robust predictor of fracture in clinical populations; this is not affected by preceding BMD change or recent osteoporosis therapy.
Keywords: Bone mineral density; Densitometry; Fracture prediction; Osteoporosis treatment.
Similar articles
-
Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study.Osteoporos Int. 2019 Jul;30(7):1445-1453. doi: 10.1007/s00198-019-04975-y. Epub 2019 Apr 23. Osteoporos Int. 2019. PMID: 31016351
-
Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry.Osteoporos Int. 2018 Mar;29(3):759-767. doi: 10.1007/s00198-018-4415-y. Epub 2018 Feb 5. Osteoporos Int. 2018. PMID: 29404625
-
Spine bone texture assessed by trabecular bone score (TBS) predicts osteoporotic fractures in men: the Manitoba Bone Density Program.Bone. 2014 Oct;67:10-4. doi: 10.1016/j.bone.2014.06.034. Epub 2014 Jul 2. Bone. 2014. PMID: 24998455
-
Use of Trabecular Bone Score (TBS) as a Complementary Approach to Dual-energy X-ray Absorptiometry (DXA) for Fracture Risk Assessment in Clinical Practice.J Clin Densitom. 2017 Jul-Sep;20(3):334-345. doi: 10.1016/j.jocd.2017.06.019. Epub 2017 Jul 19. J Clin Densitom. 2017. PMID: 28734710 Review.
-
Screening for Osteoporosis to Prevent Fractures: A Systematic Evidence Review for the US Preventive Services Task Force.JAMA. 2025 Feb 11;333(6):509-531. doi: 10.1001/jama.2024.21653. JAMA. 2025. PMID: 39808441
Cited by
-
Association between subclinical thyroid dysfunction and change in bone mineral density in prospective cohorts.J Intern Med. 2018 Jan;283(1):56-72. doi: 10.1111/joim.12688. Epub 2017 Oct 16. J Intern Med. 2018. PMID: 29034571 Free PMC article.
-
Update on the Role of Neuropeptide Y and Other Related Factors in Breast Cancer and Osteoporosis.Front Endocrinol (Lausanne). 2021 Aug 6;12:705499. doi: 10.3389/fendo.2021.705499. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34421823 Free PMC article. Review.
-
Demystifying the Risk Factors and Preventive Measures for Osteoporosis.Indian J Orthop. 2023 Sep 14;57(Suppl 1):94-104. doi: 10.1007/s43465-023-00998-0. eCollection 2023 Dec. Indian J Orthop. 2023. PMID: 38107819 Free PMC article. Review.
-
Accelerated Bone Loss in Older Men: Effects on Bone Microarchitecture and Strength.J Bone Miner Res. 2018 Oct;33(10):1859-1869. doi: 10.1002/jbmr.3468. Epub 2018 Jun 12. J Bone Miner Res. 2018. PMID: 29750848 Free PMC article.
-
Genetically modified stem cells for osteoporosis: a systematic review and meta-analysis of preclinical studies.BMC Musculoskelet Disord. 2025 Mar 14;26(1):259. doi: 10.1186/s12891-025-08507-0. BMC Musculoskelet Disord. 2025. PMID: 40087619 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical